Laura Sun, PharmD^1*, Kathryn T. Maples, PharmD^1*, Kevin H. Hall, PharmD^1*, Yuan Liu, PhD^2*, Yichun Cao, MPH^2*, Nisha S. Joseph, MD³, Craig C Hofmeister, MD⁴, Jonathan L. Kaufman, MD⁴, Madhav Dhodapkar, MBBS⁴, Ajay K. Nooka, MD, MPH, FACP⁴, Sagar Lonial, MD⁴ and R Donald Harvey, PharmD⁵

¹Department of Pharmacy, Winship Cancer Institute of Emory University, Atlanta, GA
²Department of Biostatistics and Bioinformatics, Winship Cancer Institute of Emory University, Atlanta, GA
³Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Louisville, KY
⁴Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁵Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Cyrille Hulin^1*, Aurore Perrot, MD, PhD^2*, Margaret Macro, MD^3*, Anne Vekhoff, MD^4*, Xavier Leleu, MD, PhD⁵, Lionel Karlin^6*, Salomon Manier, MD, PhD⁷, Laure Vincent, MD^8*, Abderrazak El Yamani, MD^9*, Wajed Abarah, MD^10*, Régis Kaphan, MD^11*, Charles Zarnitsky, MD^12*, Daniel Re, MD^13*, Laure Christophe, MD^14*, Olivier Fitoussi, MD^15*, Nathalie Texier^16*, Raphael Germain, MSc^17*, Marion Willaime, MSc^17* and Olivier Decaux, MD, PhD^18*

¹Hôpital Haut Leveque, University Hospital, Pessac, France
²Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
³Hématologie clinique, IBHN - CHU de Caen, Caen, France
⁴Hématologie clinique et Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France
⁵Department of Oncology, Hematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France
⁶Service d’Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁷Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
⁸Department of Hematology, Montpellier University Hospital, Montpellier, France
⁹Consultations externes d'oncologie, CH de Blois, Blois, FRA
¹⁰Hématologie et thérapie cellulaire, GHEF, site de Meaux, MEAUX, France
¹¹Oncologie-Hématologie, CH de Cannes, Cannes, FRA
¹²Rhumatologie, GHH - Hôpital Jacques Monod, Montivilliers, FRA
¹³Médecine interne oncologie, CH d'Antibes, Juan-les-Pins, Antibes, FRA
¹⁴Oncologie Hématologie, Hôpital Louis Pasteur de Chartres, Le Coudray, France
¹⁵Service d’oncologie-hématologie-radiothérapie, Polyclinique Bordeaux-Nord, Bordeaux, France
¹⁶Epidémiologie, Kappa Santé, PARIS, France
¹⁷Epidémiologie, Kappa Santé, Paris, France
¹⁸Service d'hématologie clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France

Jens Hillengass, MD, PhD¹, Michaela Hillengass, RN, PT ACSM^2*, Nathan W. Sweeney, PhD³, Thomas H. Molina, BS^3*, Jennifer M. Ahlstrom, BA^3*, Rikki Cannioto, PhD^2*, Kirsten Moysich, PhD^2* and Janine M. Joseph, MS^2*

¹Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³HealthTree Foundation, Lehi, UT

Marcelo Capra, MD, PhD¹, Thomas Martin, MD², Philippe Moreau, MD^3*, Gracia Martinez, MD, PhD^4*, Albert Oriol, MD^5*, Youngil Koh, MD, PhD⁶, Hang Quach⁷, Kwee Yong^8*, Andreea Rawlings^9*, Christina Tekle, PhD^9*, Sandrine Macé, PhD^10*, Marie-Laure Risse^11* and Ivan Spicka, MD, Prof, PhD^12*

¹Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
²Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
³Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
⁴Hospital das Clínicas, Faculdade de Medicina of Universidade de São Paulo, Sao Paulo, Brazil
⁵Institut Josep Carreras and Institut Catala d’Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain
⁶Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷Clinical Haematology Service, St. Vincent’s Hospital, Melbourne, VIC, Australia
⁸Department of Haematology, University College Hospital, London, United Kingdom
⁹Sanofi, Cambridge, MA
¹⁰Sanofi, Vitry-Sur-Seine, France
¹¹Sanofi, Vitry-sur-Seine, France
¹²1st Department of Medicine—Department of Hematology, 1st Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic

Nadine Abdallah, MD¹, Hiroki Nagayama^2*, Naoki Takahashi^2*, Wilson I. Gonsalves, MD³, Amie Fonder, PA-C^3*, Angela Dispenzieri, MD³, David Dingli, MD, PhD³, Francis K. Buadi, MB⁴, Martha Q. Lacy, MD⁵, Miriam A. Hobbs, APRN, CNP, DNP^3*, Morie A. Gertz, MD, MACP³, Moritz Binder, MD, MPH³, Prashant Kapoor, MD⁶, Rahma M Warsame, MD⁶, Suzanne R. Hayman, MD³, Taxiarchis Kourelis, MD³, Yi L. Hwa, NP³, Yi Lin, MD, PhD³, Robert A. Kyle, MD⁷, S. Vincent Rajkumar, MD^3*, Stephen Broski, MD^8* and Shaji K Kumar, MD⁶

¹Hematology, Mayo Clinic, Rochester, MN
²Radiology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo clinic college of medicine, Rochester, MN
⁵Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁶Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN
⁸Mayo Clinic, Rochester, MN

Iloabueke Chineke, MD¹, Betsy Wertheim^2*, Denise Roe, DrPH, MS^3*, Ashley Larsen, MS^4*, Victoria A. Vardell, MD⁵, Douglas W. Sborov, MD⁶, Damian J. Green, MD⁷, Michaela Liedtke, MD⁸, Marie Okoniewski, MD^9*, Mohammed Wazir, MD^10*, Omar Nadeem, MD¹¹, Levanto Schachter, DO, MS¹², David Coffey, MD¹³, Krisstina L. Gowin, DO¹⁴ and Dominique DeGraaff^15*

¹Hematology/Medical Oncology, University of Arizona, Tucson, AZ
²Cancer Center, University of Arizona, Tucson, AZ
³Epidemiology and Biostatistics, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ
⁴Department of Medicine, University of Arizona, Tucson, AZ
⁵Department of Internal Medicine, University of Utah, Salt Lake City, UT
⁶Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT
⁷Fred Hutchinson Cancer Center, Seattle, WA
⁸Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁹Harvard Medical School, Dana-Faber Cancer Institute, Boston
¹⁰Division of General Internal Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
¹¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹²Oregon Health and Science University, Portland, OR
¹³Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami
¹⁴Department of Hematology, University of Arizona, Tucson, AZ
¹⁵University of Washington, Seattle

Francesca Fazio^1*, Martina Gherardini^1*, Tommaso Za, MD^2*, Elena Rossi, MD, PhD^2*, Francesca Di Landro^2*, Sonia Morè^3*, Maria Valentina Manieri^3*, Francesca Fioritoni, MD^4*, Velia Bongarzoni, MD^5*, Svitlana Gumenyuk^6*, Angela Rago, MD^7*, Maria Grazia Garzia, MD^8*, Stefano Angelini^9*, Chiara Masucci^10*, Luca Franceschini, M.D., PhD^11*, Alfonso Piciocchi^12*, Piero Galieni, MD^9*, Luca De Rosa^8*, Francesco Pisani^6*, Stefano Pulini^4*, Massimo Offidani, MD^3*, Valerio De Stefano, MD^2*, Maurizio Martelli, MD^1* and Maria Teresa Petrucci, MD¹

¹Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
²Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy
³Clinica di Ematologia, Azienda Ospedaliero-Universitaria, Ospedali Riunti di Ancona, Ancona, Italy
⁴Department of Hematology, Transfusion Medicine and Biotechnology, "Santo Spirito" Civic Hospital, Pescara, Italy
⁵Hematology Unit, Azienda Ospedaliera Complesso Ospedaliero San Giovanni - Addolorata, ROMA, ITA
⁶Hematology, Regina Elena National Cancer Institute, Rome, Italy
⁷UOSD Ematologia, ASL Roma 1, Rome, Italy
⁸UOC Ematologia e Trapianto di cellule staminali, Azienda Ospedale San Camillo, Rome, Italy
⁹U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno, Ascoli Piceno, Italy
¹⁰Hematology Ospedale Santa Maria Goretti Latina - Sapienza University of Rome, Latina, Italy
¹¹Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
¹²Italian Group For Adult Hematologic Diseases (GIMEMA), Roma, ITA

Shuzhao Chen^1*, Yun Wang, MD, PhD^1*, Kunying Xie^2*, Limei Zhang^1*, Qianqian Huang^1* and Yang Liang, MD, PhD¹

¹State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
²Affiliated Hospital of North Sichuan Medical College, Nanchong, China

Efstathios Kastritis, MD^1*, Panagiotis Malandrakis, MD^2*, Vasiliki Spiliopoulou, MD^3*, Ioannis Ntanasis-Stathopoulos, MD^3*, Eirini Solia^3*, Foteini Theodorakakou, MD^2*, Rodanthi Syrigou, MD^3*, Nikoletta-Aikaterini Kokkali^3*, Magdalini Migkou, MD^2*, Evangelos Eleutherakis Papaiakovou, MD^3*, Despina Fotiou, MD^2*, Maria Roussou, MD^3*, Nikolaos Kanellias, MD^4*, Maria Gavriatopoulou, MD^2*, Evangelos Terpos, MD, PhD³ and Meletios A. Dimopoulos, MD³

¹Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, ATHENS, Greece
²Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece

Sejin Kim^1*, Hyungwoo Cho, MD^2*, Miyoung Kim, MD, PhD^3*, Yoon Seok Choi, MD, PhD⁴ and Dok Hyun Yoon, MD, PhD^5*

¹Department of Oncology, Asan Medical center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
²Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Department of Laboratory Medicine, Asan Medical center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
⁵Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Vishal Bhatnagar¹, Bindu Kanapuru, MD^2*, Laura Fernandes^3*, Ting-Yu Chen^4*, Mallorie H. Fiero^4*, Erica Horodniceanu^1*, Nicole Gormley, MD⁵, Catherine Lerro^6*, Fatima Rizvi^6*, Yuan-Li Shen^4*, Felice Yang^5*, Anna Barcellos^3*, Andrew J. Belli^3*, Eric Hansen^3*, Ching-Kun Wang^3*, Donna Rivera^6* and Paul Kluetz^6*

¹Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD
²Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Vienna, VA
³COTA, Inc, New York, NY
⁴Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
⁵Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
⁶Oncology Center of Excellence, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD

Yoshinobu Konishi, MD, PhD^1,2*, Romanos Sklavenitis-Pistofidis, MD^2,3, Michelle P. Aranha, PhD^2,3*, Ting Wu, MS^2,4*, Hong Yue, PhD^5,6*, Elizabeth D. Lightbody, PhD^2,3, Mahshid Rahmat, PhD^2,3*, Michael Timonian, MD^2,3*, Shohreh Varmeh, PhD^3*, Daniel Heilpern-Mallory, BS^2,3*, Michael P. Agius, PhD^2,3*, Nang Kham Su, MSc^3*, Jacqueline Perry, MPH^3*, Erica Horowitz, BA^3*, Maya I. Davis, BA^3*, Anna V. Justis^3*, Radoslaw P. Nowak, PhD^5,6*, Mark Hamilton, PhD^7*, Daniel Auclair, PhD^7,8, Catherine R. Marinac, PhD³, Eric S. Fischer, PhD^5,6*, Gad Getz, PhD^2,4* and Irene Ghobrial, MD^2,3

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
²Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA
⁵Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
⁶Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA
⁷Multiple Myeloma Research Foundation, Norwalk, CT
⁸Hematology R&D, AstraZeneca, Waltham, MA

Vahid Azimi, MD, MS^1*, Michael J Slade, MD, MS², Mark A Fiala, PhD^2*, Julie M Fortier, PhD^2*, Keith E Stockerl-Goldstein, MD², John L Frater, MD³, Jonathan R Brestoff, MD, PhD, MPh^1*, Ronald Jackups Jr., MD, PhD^1* and Mark A Zaydman, MD, PhD^1*

¹Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO
²Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, St. Louis, MO
³Department of Pathology and Immunology, Division of Anatomic and Molecular Pathology, Washington University School of Medicine, St Louis, MO

Julia E. Wiedmeier, MD, MPH¹, Michael A. Golafshar^2*, Katie L. Kunze, PhD^2*, Edward D. Esplin^3*, Robert L. Nussbaum^3*, A. Keith Stewart, MBChB⁴, Jewel Samadder^5*, P. Leif Bergsagel, MD¹ and Rafael Fonseca, MD¹

¹Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
²Division of Health Services Research, Mayo Clinic, Phoenix, AZ
³Invitae Labs, San Francisco, CA
⁴Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ

Evguenia Ouchveridze, MD¹, Chandandeep Singh, MD^1*, Shebli Atrash, MD^2,3, Barry Paul, MD, MS^3,4, Meera Mohan, MD^3,5, Omar Alkharabsheh, MBBS^3,6, Aimaz Afrough, MD^3,7, Wei Cui, MD^3,8*, Zahra Mahmoudjafari, PhD^3,9*, Al-Ola Abdallah, MD^10,11 and Hamza Hashmi, MD^3,12

¹University of Kansas Medical Center, Westwood, KS
²Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
³US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, KS
⁴Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Mitchell Cancer Institute, University of South Alabama, Mobile, AL
⁷Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁸University of Kansas Medical Center, Kansas City, KS
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹¹US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS
¹²Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC

Jon Þórir Oskarsson, MSc^1*, Sæmundur Rögnvaldsson, MD^2,3*, Sigrún Thorsteinsdóttir, MD, PhD^1,4, Hrafnhildur Una Þórðardóttir^1*, Gudlaug Katrin Hakonardottir^1*, Steinar Bragi Gunnarsson^1*, Gudrún Ásta Sigurdardóttir^1*, Ásdis Rósa Thórdardottir^1*, Gauti Gíslason^1*, Andri Olafsson^1*, Jon Kristinn Sigurdsson^1*, Brynjar Vidarsson, MD³, Páll Torfi Onundarson, MD³, Bjarni Agnar Agnarsson, MD^3*, Robert Palmason^1,3,5*, Margrét Sigurdardóttir, MD^3*, Ingunn Thorsteinsdóttir, MD, PhD^3*, Ísleifur Ólafsson, MD, PhD^3*, Juan Flores-Montero, MD, PhD^6*, Alberto Orfao, MD, PhD⁶, Brian G.M. Durie, MD⁷, Thorvardur Jon Love, MD, PhD^1,3* and Sigurdur Y Kristinsson, MD, PhD^1,3

¹Faculty of Medicine, University of Iceland, Reykjavik, Iceland
²Faculty of Medicine, University of Iceland, Reykjavík, Iceland
³Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
⁴Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
⁵Skåne University Hospital, Lund, Sweden
⁶Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain
⁷Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

Steven J Gibson, MD^1*, John D Cooper, MD^2*, Jennifer A Thornton, PhD^3*, Kevin Pham^4*, Kevin Sunderland^4* and Christin B DeStefano, MD⁵

¹Internal Medicine Residency Program, National Capital Consortium, Bethesda, MD
²Walter Reed National Military Medical Center, Bethesda, MD
³Clinical Investigation Facility, David Grant USAF Medical Center, Fairfield, CA
⁴David Grant USAF Medical Center, Fairfield, CA
⁵Hematology/Oncology, Walter Reed National Military Medical Center, Bethesda, MD

María Isabel Morales-Lozano^1*, María Marcos Jubilar^2*, Lidia Sancho Rodriguez^1*, Ana Alfonso-Pierola, MD, PhD^3*, Jorge M Nuñez-Cordoba^4*, Elena Prieto Azcárate^1*, Luis Esteban Tamariz-Amador, MD^2*, Juan J Rosales Castillo^1*, Maria Luisa Palacios-Berraquero, MD^2*, Fernando Guillen Valderrama^1*, Andrea Manubens Guarch^2*, Angela Bronte Viedma^1*, Sofía Huerga Domínguez^2*, Victoria Betech Antar^1*, Maria Panizo Inogés, MBBS^5*, Felipe Prosper, MD^2*, Ramon Lecumberri, MD, PhD^2*, Jesús San-Miguel, MD, PhD⁶, Paula Rodríguez Otero, MD, PhD^2* and María José García Velloso^1*

¹Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain
²Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain
³Department of Hematology, Clinica Universidad de Navarra, Navarra, Spain
⁴Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain
⁵Department of Hematology, Clinica Universidad De Navarra, PAMPLONA, AL, ESP
⁶Clinica Universitaria de Navarra, Navarra, Spain

Paolo Milani, MD, PhD¹, Claudia Bellofiore, MD^2,3*, Marco Basset, MD PhD^4*, Andrea Foli, MD^5*, Pietro Benvenuti, MD^3*, Francesca Fabris, MD^6*, Martina Nanci, MD^7*, Mario Nuvolone, MD, PhD^3*, Giampaolo Merlini, MD^8,9* and Giovanni Palladini, MD PhD¹⁰

¹Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
²UOC di Ematologia, AOU Policlinico Rodolico San Marco, Catania, Italy, Italy
³Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁴Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy, Italy
⁵Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
⁶Amyloidosis Research and Treatment Center,, Pavia, ITA
⁷Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, ITA
⁸Amyloidosis Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
⁹Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
¹⁰Department of Molecular Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy

Mohamed Elmeliegy, PhD^1*, Andrea Viqueira, MD^2*, Erik Vandendries, MD, PhD³, Anne Hickman^4*, Jennifer Hibma^1*, Hoi-Kei Lon^5*, Joseph Piscitelli^1*, Pooneh Soltantabar^1*, Diane Wang^1*, Sibo Jiang, PhD^6*, Gregory Finn, PhD^7* and Akos Czibere^8*

¹Global Product Development, Pfizer Inc, San Diego, CA
²Pfizer SLU, Madrid, Spain
³Pfizer Inc, Cambridge, MA
⁴Global Product Development, Pfizer Inc, Groton, CT
⁵Global Product Development, Pfizer Inc., San Diego, CA
⁶Early Clinical Development, Pfizer Inc, San Diego, CA
⁷Early Clinical Development, Pfizer Inc, Cambridge, MA
⁸Global Product Development, Pfizer Inc, Cambridge, MA

Arghya Ray, PhD¹, Ting DU, PhD¹, Krishan Chauhan^2*, Dharminder Chauhan, PhD^3* and Kenneth C. Anderson, MD⁴

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Department of Biomedical Engineering, Wentworth Institute of Technology, Boston, MA
³The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Nathan W. Sweeney, PhD, Emily W. Ballard, BS^*, Eduardo Franco Hernandez, MD^*, Andrea Isabel Robles Espinoza, MD^*, Andrea Jimena Cuevas Vicencio, MD^*, Patricia Alejandra Flores Pérez, MD^*, Thomas H. Molina, BS^*, Jennifer M. Ahlstrom, BA^* and Jay R. Hydren, PhD^*

HealthTree Foundation, Lehi, UT

Cecilia Bonolo De Campos, PhD^1*, James B Smadbeck, PhD^2*, Mariano Arribas^1*, Neeraj Sharma, PhD³, Gregory J Ahmann, BS⁴, Shaji K Kumar, MD⁵, A. Keith Stewart, MBChB⁶, Rafael Fonseca, MD⁷, P. Leif Bergsagel, MD¹, Yan Asmann, PhD⁸, Linda B. Baughn, Ph.D⁹ and Esteban Braggio, PhD¹⁰

¹Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
²Center for Individualized Medicine, Biomarker Discovery, Mayo Clinic, Rochester, MN
³Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
⁵Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁶University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁸Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL
⁹Division of Laboratory Genetics, Mayo Clinic, Rochester, MN
¹⁰Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ

Walker M Schmidt, BS¹, Francis K. Buadi, MB², Suzanne R. Hayman, MD³, Shaji K Kumar, MD^3,4, Angela Dispenzieri, MD^3,5, David Dingli, MD, PhD³, Joselle Cook, MBBS^3,5, Martha Q. Lacy, MD⁶, Prashant Kapoor, MD⁴, Nelson Leung, MD⁷, Eli Muchtar, MD⁸, Rahma M Warsame, MD⁴, Taxiarchis Kourelis, MD³, Moritz Binder, MD³, Wilson I. Gonsalves, MD⁹ and Morie A. Gertz, MD, MACP³

¹Mayo Clinic Alix School of Medicine, Rochester, MN
²Mayo clinic college of medicine, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN
⁶Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁷Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
⁸Associate Professor of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
⁹Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN

Jian Cui, MBBS^1*, Jiahui Liu^2*, Huishou Fan^3*, Lugui Qiu⁴, Kenneth C. Anderson, MD⁵ and Gang An, MD^6*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
²National Clinical Research Center for Blood Diseases, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
⁴Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁵Dana-Farber Cancer Institute, Boston, MA
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Joshua Richter, MD¹, Darren Pan, MD, BS^2*, Taylor Salinardi, PhD^3* and Megan S. Rice, ScD, MPH^3*

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³Sanofi, Cambridge, MA

Humberto Martinez-Cordero, MD, MSc^1,2, Camila Peña, MD³, Natalia Paola Schutz, MD^4,5,6, Virginia Bove, MD^7*, Fiorella Villano, MD^8*, Rocío Osorio, MD^9*, Mauricio Chandia, MD^10*, Cecilia Beltrán, MD^11*, Javier Schulz, MD^12*, Daniela Cardemil, MD^13*, Carolina Contreras, MD^14*, Carmen Gloria Vergara, MD^14*, Javiera Donoso, MD^15*, Marcela Espinoza, MD^16*, Gabriel La Rocca, MD^17*, Hernán López-Vidal, MD^18*, Pilar León, MD^19*, Macarena Roa, MD^20*, Christine Rojas, MD^21*, Pablo Soto, MD^22*, Sandra Aranda, MD^23*, Vivianne Torres, MD^24*, Paola Ochoa, MD^25*, Patricio Duarte, MD^26,27, Guillermina Remaggi, MD^28*, Sebastian Yantorno, MD^29*, Ariel Corzo, MD^30*, Soledad Zabaljauregui, MD^31*, Claudia Shanley, MD^32*, Sergio Lopresti^33*, Sergio Orlando, MD^34*, Veronica Verri, MD^35*, Luis Darío Quiroga, MD^36*, Juan Jose Garcia, MD³⁷, Vanesa Fernandez, MD^38*, Dorotea Fantl, MD³⁹, Jhoanna Ramirez, MD^40*, Alicia Molina, MD^41*, Pilar Papilco, MD^41*, Alex Mite, MD^41*, Ines Reyes, MD⁴², Brenner Sabando Vélez, MD^43*, Francisca M. Ramirez Aspiazu, MD^44*, Claudia Lucia Sossa^45,46*, Virginia Abello, MD^46,47,48*, Henry Idrobo, MD^46,49*, Domingo Saavedra, MD^46,50*, Guillermo Quintero, MD, MBA^46,51, Lina Gaviria, MD^46,52*, Rigoberto Gomez, MD^46,53*, Monica Osuna Pérez, MD^46,54*, Alicia Henao-Uribe, MD^46,55, Luz del Carmen Tarín Arzaga, MD^56*, Omar Cantú-Martínez, MD^57*, David Gomez-Almaguer, MD⁵⁸, Yarely Itzayana García-Navarrete, MD^59*, Antonio Cruz-Mora, MD^60*, Yahveth Cantero-Fortiz, MD^61*, Guillermo J. Ruiz-Arguelles, FRCP⁶², Eloisa Riva, MD, MEd⁶³ and Isabella Novoa-Caicedo^64*

¹Instituto Nacional de Cancerologia, Bogota, Bogota, Colombia
²Master program in Epidemiology - Universidad el Bosque, Bogotá, Colombia
³Hematology Department, Hospital Del Salvador, Santiago, Chile
⁴Hospital Italiano de Buenos Aires, Buenos Aires, BA, Argentina
⁵Hematology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁶GAMM (Grupo Argentino de Mieloma Múltiple), Buenos Aires, Argentina
⁷Hospital Central de las FF.AA., Montevideo, Uruguay
⁸CASMU, Montevideo, Uruguay
⁹Hospital de Arica, Arica, Chile
¹⁰Hospital de Concepcion, Concepción, Chile
¹¹Departamento de Medicina Interna, Universidad de la Frontera, Temuco, Chile
¹²Hospital de Temuco, Temuco, Chile
¹³Hospital de Punta Arenas, Punta Arenas, Chile
¹⁴Hospital de Rancagua, Rancagua, Chile
¹⁵Hospital Sótero del Río, Santiago, Chile
¹⁶Hospital San José, Santiago, Chile
¹⁷Hospital Regional de Coyhaique, Coyhaique, Chile
¹⁸Hospital Barros Luco, Santiago, Chile
¹⁹Hospital Van Buren, Valparaiso, Chile
²⁰Hospital Del Salvador, Santiago, Chile
²¹Hospital Gustavo frieke, Viña Del Mar, Viña Del Mar, CHL
²²Hospital Dr. Eduardo Schütz Schroeder, Puerto Montt, Chile
²³Hospital San Juan de Dios, Santiago, Chile
²⁴Hospital Base de Valdivia, Valdivia, Chile
²⁵Instituto Alexander Fleming, Buenos aires, Argentina
²⁶CEMIC, Buenos Aires, Argentina
²⁷CEMIC University Hospital, Buenos Aires, Argentina
²⁸Fundaleu, Buenos Aires, Argentina
²⁹Hospital Italiano de la Plata, La Plata, Argentina
³⁰Hospital de Clinicas, Buenos Aires, Argentina
³¹Academia Nacional de Medicina, Ciudad Autonoma De Buenos Aires, BA, ARG
³²Hospital Británico, Buenos Aires, Argentina
³³Hospital Nacional Alejandro Posadas, Buenos Aires, Argentina
³⁴Hospital Rossi, La Plata, Argentina
³⁵Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina
³⁶Hospital Churruca, Buenos Aires, Argentina
³⁷Hospital Privado de Cordoba, Cordoba, Argentina
³⁸Hospital Mendez, Buenos Aires, Argentina
³⁹Hospital Italiano de Buenso Aires (HIBA), Buenos Aires, Argentina
⁴⁰Hospital Teodoro Maldonado, Guayaquil, Ecuador
⁴¹HOSPITAL IESS, Guayaquil, Ecuador
⁴²IDYTES, Guayaquil, Ecuador
⁴³IESS, GUAYAQUIL, ECU
⁴⁴HOSPITAL IESS, Guayaquil, Guayas, Ecuador
⁴⁵Hematology and Hematopoietic Stem Cell Transplantation Unit, Clinica FOSCAL, Floridablanca, Santander, Colombia
⁴⁶RENEHOC, Bogotá, Colombia
⁴⁷Servicio de Hematología, Hospital de San José., Bogota, Colombia
⁴⁸Hospital de San José, Bogota, Colombia
⁴⁹Facultad de Medicina., Universidad Del Valle, Cali, Colombia
⁵⁰Clinica Vida, Medellin, Colombia
⁵¹Hematology Department, Hospital Universitario Fundación Santa Fe de Bogotá, Bogota, Colombia
⁵²Hospital Universitario San Vicente de Paul, Medellín, Colombia
⁵³Asociación Colombiana de Hematología y Oncología, Cali, Colombia
⁵⁴Clinica Los Nogales, Bogotá, Colombia
⁵⁵Clinica De Oncologia Astorga, Medellin, Antioquia, COL
⁵⁶Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, NL, Mexico
⁵⁷Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico
⁵⁸Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, NL, Mexico
⁵⁹Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
⁶⁰Clínica Ruiz; Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
⁶¹Universidad de las Américas Puebla, San Pedro Cholula, Mexico
⁶²Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico
⁶³Cátedra de Hematología, Hospital de Clínicas, Facultad de Medicina, Montevideo, Montevideo, Uruguay
⁶⁴Facultad de Medicina, Universidad El Bosque, Bogóta, Colombia

Richard Leblanc, MD, FRCPC¹, Christopher P. Venner, MD, FRCPC², Esther Masih-Khan, PhD^3,4*, Moustafa Kardjadj, PhD^5*, Michael P. Chu, MD^6,7, Victor H Jimenez-Zepeda, MD⁸, Arleigh McCurdy, MD, BSc⁹, Kevin Song, MD, FRCPC^10,11, Michael Sebag, MD, PhD¹², Martha L Louzada, MD, MSc¹³, Hira S Mian, MD¹⁴, Darrell J White, MD¹⁵, Julie Stakiw, MD, FRCPC^16,17, Rami Kotb, MD, FRCPC¹⁸, Anthony Reiman, MD^19*, Muhammad Aslam, MD^20*, Rayan Kaedbey, MD²¹, Engin Gul, BSc, MBA^22* and Donna E. Reece, MD, FRCPC^23,24

¹Hopital Maisonneuve-Rosemont, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
²BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
³Canadian Myeloma Research Group (formerly MCRN), Toronto, Canada
⁴Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Canadian Myeloma Research Group, Toronto, ON, Canada
⁶Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada
⁷Cross Cancer Institute, Edmonton, AB, Canada
⁸Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada
⁹Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
¹⁰Division of Hematology, University of British Columbia and Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, BC, Canada
¹¹The Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, Vancouver, Canada
¹²Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
¹³University of Western Ontario, London Health Sciences Centre, London, ON, Canada
¹⁴Department of Oncology, McMaster University, Hamilton, ON, Canada
¹⁵Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
¹⁶Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁷Saskatchewan Cancer Agency, Saskatoon, SK, Canada
¹⁸Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
¹⁹Oncology, Saint John Regional Hospital, Saint John, NB, CAN
²⁰Allan Blair Cancer Center, Regina, SK, Canada
²¹Jewish General Hospital, McGill University, Montreal, Montreal, QC, CAN
²²Canadian Myeloma Research Group (CMRG), Concord, ON, Canada
²³Canadian Myeloma Research Group (CMRG), Vaughan, ON, Canada
²⁴Princess Margaret Cancer Centre, Toronto, ON, Canada

Michele Cavo, MD^1*, Sujith Dhanasiri, MPhil, MSc^2*, Valerio De Stefano, MD^3*, Angel Ramírez Payer, MD^4*, Martin Wiesholzer^5*, Yvonne Tromp^6*, Meegahage Ratnakanthi Perera⁷, Valentine Richez-Olivier^8*, Maciej Gil^9*, David Bernasconi^10* and Barbara Gamberi, MD^11*

¹Bologna University School of Medicine, Bologna, Italy
²Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
³Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
⁴Hospital Universitario Central de Asturias, Oviedo, Spain
⁵Department of Internal Medicine 1, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, Karl Landsteiner Institute for Nephrology, St. Pölten, Austria
⁶Röpcke-Zweers Hospital, Hardenberg, Netherlands
⁷Midland Regional Hospital Co. Offally, Tullamore, IRL
⁸CHU de Nice Hospital de L’Archet II, Nice, France
⁹Bristol Myers Squibb, Boudry, Switzerland
¹⁰Celgene International, Boudry, Switzerland
¹¹Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

XiaoYan Yue^1*, GaoFeng Zheng^2*, Donghua He^2*, Yang Yang^1*, Xiaoyan Han, MD^2*, Yi LI^1*, Yi Zhao^2*, Qingxiao Chen^1*, WenJun Wu^3*, He Huang⁴, Zhen Cai, PhD, MD^4* and Jingsong He, PhD^2*

¹Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
²Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
³The First Affiliated Hospital of Zhejiang Medical College, Zhejiang University, Hangzhou, China
⁴Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China

Guido Lancman, MD, MSc^1,2, Margaret Shyu, MD^3*, Megan Metzger, MD^3*, Kian Parsa, DO^3*, Hearn J. Cho, MD, PhD², Samir Parekh, MD², Joshua Richter, MD², Cesar Rodriguez, MD², Adriana Rossi, MD, MSc², Larysa Sanchez, MD², Santiago Thibaud, MD², Sundar Jagannath², Ajai Chari, MD² and Shambavi Richard, MD²

¹University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³Icahn School of Medicine at Mount Sinai, New York, NY

Roman Hajek, MD¹, Henrik Sliwka^2*, Martin Stork, MD, PhD^3*, Ivan Spicka, MD, Prof, PhD^4*, Tomas Jelinek, MD, PhD⁵, Jakub Radocha, MD, PhD^6,7*, Alexandra Jungova, MD, PhD^8*, Jiri Minarik, MD, PhD^9*, Jan Soukup, MD^10*, Nolen Joy Perualila, PhD^11*, Joris Diels, MSc^11*, Michel van Speybroeck, MSc^12*, Nichola Erler-Yates^13*, João Mendes^14*, Kai Strobel^15*, Sébastien Wischlen^16* and Maximilian Merz, MD¹⁷

¹Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
²Janssen Cilag Pharma, Wien, Austria
³Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
⁴Clinical Department of Haematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic
⁵Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
⁶4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
⁷Department of Clinical Hematology, University Hospital, Hradec Kralove, Hradec Kralove, CZE
⁸Hematology and Oncology Department, Charles University Hospital in Pilsen, Pilsen, Czech Republic
⁹Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic
¹⁰Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
¹¹Janssen Pharmaceutica NV, Beerse, Belgium
¹²Data Sciences, Janssen Pharmaceutica N.V., Beerse, Belgium
¹³Janssen-Cilag GmbH, Neuss, Germany
¹⁴Janssen Cilag, Porto Salvo, Portugal
¹⁵Oncology Information Service (O.I.S), Freiburg, Germany
¹⁶CancerDataNet GmbH, Basel, Switzerland
¹⁷Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

Michelle A. Quan, MD¹, Kwan-Keat Ang, MD^1*, Joseph M Tuscano, MD², Mehrdad Abedi, MD², Brian A. Jonas, MD, PhD³, Naseem S Esteghamat, MD², Jeanna L Welborn, MD⁴, Paul R. Kaesberg, MD⁴ and Aaron S Rosenberg, MD^2,5

¹Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA
²Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
³Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
⁴Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
⁵Cancer Center Data Informatics Integration Initiative (CDI3), University of California Davis Health System Department of Research Informatics, Sacramento, CA

Eric Oksenhendler^1,2*, Camille Rasmussen^3*, David Boutboul, MD, PhD^4*, Lionel Galicier, MD^5* and Laurence Gérard^6*

¹National Reference Center for Castleman Disease, APHP - Hôpital St Louis, Paris, France
²Paeris Université, Paris, France
³Department of Clinical Immunology, Hopital Saint-Louis, Paris, France
⁴National Reference Center for Castleman Disease, Hôpital Saint-Louis, Paris, FRA
⁵Centre de Réference National Maladie de Castleman, Paris, France
⁶Department of Clinical Immunology, Hôpital Saint-Louis, AP-HP, Paris, FRA

Habib Hamidi, MPH, PhD^1*, Teiko Sumiyoshi^1*, Cedric E. Dos Santos, PhD², Samuel Tracy, PhD^1*, Hearn J. Cho, MD, PhD^3,4, Stephanie Hilz, PhD^5* and Vivek S. Chopra, PhD^2*

¹Genentech, Inc., South San Francisco, CA
²Genentech, Inc., San Francisco, CA
³Multiple Myeloma Research Foundation, Norwalk, CT
⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Genentech, South San Francisco, CA

Rakesh Popat^1*, Sikander Ailawadhi², David Kleinman, MD^3*, Sue Perera, PhD^4*, Boris Gorsh, PharmD^5*, Caitlin Thomas, MSc^6*, Sarah Mulnick, BA^7*, Alicia O'Neill, MA^5*, Melissa Ross, PhD^7*, Prani Paka, PharmD^5*, Maya Hanna, PhD^5*, Alexa Molinari, PharmD^5,8*, Shivaranjani Naine, MSc^5* and Heather Gelhorn, PhD^7*

¹University College London Hospitals, NHS Foundation Trust, London, United Kingdom
²Mayo Clinic, Jacksonville, FL
³Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY
⁴GSK, London, United Kingdom
⁵GSK, Upper Providence, PA
⁶Patient Centered Research Evidera, London, United Kingdom
⁷Patient-Centered Research, Evidera, Bethesda, MD
⁸Rutgers Center for Health Outcomes, Policy, and Economics, Rutgers, The State University of New Jersey, Piscataway, NJ

Jianhua Du^1*, Miao Chen^2*, Li Huo^2*, Wenjia Zhu^2*, Huijuan Wang, MD^3*, Yun Leng^4*, Shuangjiao Liu, BA^5* and Junling Zhuang, MD⁵

¹Peking Union Medical College Hospital, Beijing, AL, China
²Peking Union Medical College Hospital, Beijing, China
³Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
⁴Beijing Chao-Yang Hospital, Capital Medical University, Beijing, CHN
⁵Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

Lindsay Hammons, MD¹, Shabi Haider^2*, Marcelo C Pasquini, MD, MS³, Saurabh Chhabra, MD, MS⁴, Sabarinath Radhakrishnan^5*, Anthony E. Zamora, PhD^2*, Meera Mohan, MD², Jing Dong, PhD⁶, Siegfried Janz⁶, Anita D'Souza, MD, MS⁷, Parameswaran Hari, MD, MRCP² and Binod Dhakal, MBBS⁸

¹Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²Medical College of Wisconsin, Milwaukee, WI
³CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
⁴Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵Medical college of Wisconsin, Milwaukee, WI
⁶Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁷Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
⁸Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI

Hussein Awada^1*, Adel Hajj Ali, MD^2*, Danai Dima, MD¹, Lauren M. Granat, DO, MS^3*, Michael Sheu, MD^3*, Puneet Dhillon, DO^3*, Mikhaila Rice, PharmD^4*, Heena P Kurish, PharmD^4*, Louis S. Williams, MD⁵, Faiz Anwer, MD⁵ and Jack Khouri, MD⁵

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH
³Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH
⁴Department of Pharmacy, Cleveland Clinic, Cleveland, OH
⁵Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Laurent Garderet, MD, PhD¹, Hafida Ouldjeriouat^2*, Mohamed-Amine Bekadja^3*, Elisabeth Daguenet, PhD^4*, Laure Vincent, MD^5*, Damien Roos Weil, MD, PhD^6*, Marguerite Vignon, MD^7*, Mohamad Mohty, MD PhD⁸, Julie Abraham, MD^9*, Martine Escoffre-Barbe, MD^10*, Bruno Lioure, MD^11*, redhouane Ahmed Nacer^12*, Denis Caillot, MD^13*, Clara Mariette, MD^14*, Lionel Karlin^15*, Pierre Morel, MD^16*, Lila Gilis, MD^17*, Emanuelle Leray^18*, Anaise Blouet, MD^19*, Nicole Raus, Data Manager^20*, Marie Robin, MD, PhD²¹, jean Jacques Boffa^22*, Pierre Ronco^23*, Marie Thérèse Rubio, MD, PhD^24*, Jerome Lambert, MD, PhD^25* and Jérôme Cornillon, MD^26*

¹Service Hematologie, Sorbonne Université, Hopital Pitié Salpêtière APHP, Paris, France
²hematology department, CHU Oran, Oran, Algeria
³Department of Hematology and Cell Therapy, EHU 1st Novembre 1954 Bir el Djir Usto, University Ahmed Benbella 1, Oran, Algeria
⁴Institut de Cancérologie Lucien Neuwirth, Saint Priest En Jarez, France
⁵Department of Hematology, Montpellier University Hospital, Montpellier, France
⁶Hematology department, Sorbonne Université Hôpital Pitié Salpêtrière APHP, Paris, FRA
⁷Cochin Hospital, Hematology Department, Paris, France
⁸EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
⁹Clinical Hematology Service, CHU Limoges, Limoges, FRA
¹⁰Hôpital de Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France
¹¹Département d'Hématologie et d'Oncologie, CHU Strasbourg, Strasbourg, France
¹²department of hematology and bone marrow transplant, CPMC Algiers, Algiers, Algeria
¹³Hematology Department, Dijon University Hospital, Dijon, France
¹⁴Service d'Hématologie, CHU de Grenoble, Grenoble, France
¹⁵Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Bénite, France
¹⁶Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Salouel, France
¹⁷Centre Hospitalier Lyon Sud, Pierre Benite, France
¹⁸Hematology department, CH Argenteuil, Argenteuil, France
¹⁹Service oncologie-hématologie, Centre Hospitalier, Cholet, Cholet, France
²⁰SFGM-TC, Lyon, France
²¹Hopital Saint-Louis, Paris Cedex 10, France
²²Nephrology department, Sorbonne Université Hôpital Tenon APHP, Paris, France
²³INSERM Umr_s 1155, Paris, FRA
²⁴Hopital d`Enfants, Nancy, France
²⁵Biostatistics Department, University of Paris, AP-HP, Saint Louis Hospital, Paris, FRA
²⁶Hematology department, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez, France

Massimo Offidani, MD^1*, Michele Cavo, MD^2*, Daniele Derudas^3*, Francesco Di Raimondo, MD⁴, Antonio Cuneo^5*, Luca Baldini, MD^6*, Roberta Della Pepa, MD^7*, Maurizio Musso, MD^8*, Mario Boccadoro, MD⁹, Pellegrino Musto, MD¹⁰, Maria Teresa Petrucci, MD¹¹ and Angelo Belotti, MD^12*

¹Clinica di Ematologia, Azienda Ospedaliero-Universitaria, Ospedali Riunti di Ancona, Ancona, Italy
²Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
³Ospedale Oncologico "A. Businco", Struttura Complessa di Ematologia e Centro Trapianto Cellule Staminali Emopoieti, Cagliari, Italy
⁴Divisione di Ematologia, Ospedale Ferrarotto, A.O.U. Policlinico-OVE, Università di Catania, Catania, Italy
⁵St. Anna University Hospital, Ferrara, Italy
⁶UO Ematologia, Fondazione IRCCS Cà Granda, OM Policlinico, Università degli Studi, Milan, Italy
⁷Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
⁸U.O.C. OncoEmatologia e TMO, Dipartimento Oncologico, La Maddalena, Palermo, Palermo, Italy
⁹Hematology Division, Department of Molecular Biotechnologies and Health Sciences, Cattedra Ematologia, Torino, Italy
¹⁰“Aldo Moro” University School of Medicine and AOU Consorziale Policlinico, Bari, Italy
¹¹Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
¹²Hematology, ASST Spedali Civili di Brescia, Brescia, Italy

Yael Kusne, MD¹, Rodrigo Fonseca, MD^2*, Mariano Arribas^2*, Molly Klanderman, PhD^3*, Julia E. Wiedmeier, MD, MPH¹, Craig B. Reeder, MD², Jeremy T. Larsen^4*, P. Leif Bergsagel, MD², Julie L Rosenthal, MD^5* and Rafael Fonseca⁶

¹Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
²Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
³Department of Quantitative and Health Sciences, Mayo Clinic, Phoenix, AZ
⁴Division of Hematology, Mayo Clinic, Phoenix, AZ
⁵Division of Cardiology, Mayo Clinic, Phoenix, AZ
⁶Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ

Abdul Rahman Al Armashi, MD^1*, Dina Elantably, MD^2*, Jiasheng Wang, MD¹, Anas Al Zubaidi, MD^3* and Akram Alkrekshi, MD^4*

¹Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
²Department of Internal Medicine, Case Western Reserve University MetroHealth Medical Center, Cleveland, OH
³Johns Hopkins University, Baltimore, MD
⁴Department of Internal Medicine, Case Western Reserve University MetroHealth Medical Center, Westlake, OH

David J. Lee, MD^1,2,3,4, Habib El-Khoury, MD^3,5, Luca Bertamini, MD^3,5*, Jean-Baptiste Alberge, PhD^3,4,5*, Maya I. Davis, BA^3,5*, Jacqueline Perry, MPH^3,5*, Dhananjay Sakrikar, PhD^6*, David Barnidge, PhD^6*, Mark C. Perkins, PhD^7*, Stephen Harding, PhD⁷, Derek Troske, BS^6*, Audrey Pentz, B.Rad(T)^8*, Thulisile Hlubi^8*, Natalie Smyth, MS^9*, Anna Cowan, BA^10*, Angela C. Tramontano, MPH^5*, Gad Getz, PhD^3,4,11,12*, Timothy R. Rebbeck, PhD^5,13*, Maureen Joffe, PhD^8*, Wenlong Carl Chen, PhD^8,14,15*, Catherine R. Marinac, PhD^3,5,16 and Irene Ghobrial, MD^3,5,16

¹Department of Medicine, Massachusetts General Hospital, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA
³Harvard Medical School, Boston, MA
⁴Broad Institute of MIT and Harvard, Cambridge, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶The Binding Site Inc., Rochester, MN
⁷The Binding Site Inc., Birmingham, United Kingdom
⁸Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa
⁹Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
¹⁰Alix School of Medicine, The Mayo Clinic, Rochester, MN
¹¹Center for Cancer Research, Massachusetts General Hospital, Boston, MA
¹²Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA
¹³Harvard T.H. Chan School of Public Health, Boston, MA
¹⁴Faculty of Health Sciences, University of the Witwatersrand, Sydney Brenner Institute for Molecular Bioscience, Johannesburg, South Africa
¹⁵National Health Laboratory Service, National Cancer Registry, Johannesburg, South Africa
¹⁶The Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA

Eli Muchtar, MD¹, Surendra Dasari, PhD^2*, Martha Grogan, MD^3*, Morie A. Gertz, MD, MACP⁴, Martha Q. Lacy, MD⁵, Francis K. Buadi, MB⁶, David Dingli, MD, PhD⁷, Taxiarchis Kourelis, MD⁷, Itzhak Z. Attia, PhD^8*, Francisco Lopez-Jimenez, MD, MBA^9*, Dennis Murphree, PhD^10*, Paul A. Friedman, MD^8*, Shaji K Kumar, MD¹¹ and Angela Dispenzieri, MD⁴

¹Associate Professor of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Cardiology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic Rochester, Rochester, MN
⁶Mayo clinic college of medicine, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN
⁹Preventive Cardiology, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
¹⁰Mayo Clinic, Artificial Intelligence and Informatics, Rochester, MN
¹¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Sireesha Asoori, MBBS, MPH^1*, Alfred Chung, MD², Nina Shah, MD¹, Shagun Arora, MD², Jeffrey L. Wolf, MD², Thomas Martin, MD³ and Sandy W. Wong, MD²

¹Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
²Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
³UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Jonathan L. Kaufman, MD¹, Robert Z. Orlowski, MD, PhD², Andras Strassz, MD³, Andreas Pahl, PhD⁴, Thorsten Michaels^3*, Anette Last^3*, Hajnalka Szaboki, MD^3*, Garrit Jentsch^5*, Oliver Schoenborn-Kellenberger, MSc^6* and Marc-Steffen Raab^7,8,9*

¹Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
²Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
³Heidelberg Pharma AG, Ladenburg, Germany
⁴Heidelberg Pharma, Ladenburg, Germany
⁵BAST GmbH, Heidelberg, Germany
⁶Cogitars GmbH, Heidelberg, Germany
⁷CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁸Max-Eder Group, Experimental Therapies for Hematologic Malignancies, German Cancer Research Center, Heidelberg, Germany
⁹Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Ricardo D Parrondo, MD¹, Lindsay Brooke Gardner, MS, MD¹, Mohamad Alhaj Moustafa, MD¹, Vivek Roy, MD², Taimur Sher, MD¹, Ahsan Rasheed^2*, Rahma M Warsame, MD³, Jeremy T. Larsen^4*, Wilson I. Gonsalves, MD⁵, Taxiarchis Kourelis, MD⁵, Prashant Kapoor, MD³, Rafael Fonseca, MD⁴, Asher Chanan-Khan, MD² and Sikander Ailawadhi⁶

¹Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
³Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁴Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Division of Hematology, Mayo Clinic, Jacksonville, FL

Maria Papatsirou, BSc^1*, Christos K. Kontos, PhD^1*, Ioannis Ntanasis-Stathopoulos, MD^2*, Paraskevi Karousi, BSc^1*, Panagiotis Malandrakis, MD^2*, Foteini Theodorakakou, MD^2*, Christine Ivy Liacos, MSc^2*, Aikaterini-Anna Liosi, BSc^1*, Maria-Anna Kalioraki, BSc^1*, Nefeli Mavrianou-Koutsoukou, BSc^2*, Despina Fotiou, MD^2*, Magdalini Migkou, MD^2*, Maria Gavriatopoulou, MD^2*, Efstathios Kastritis, MD^3*, Meletios-Athanasios Dimopoulos, MD, PhD², Andreas Scorilas, PhD^1* and Evangelos Terpos, MD, PhD²

¹Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
²Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
³Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, ATHENS, Greece

Nico Gagelmann^1*, Francis A. Ayuk, MD^2*, Anita Badbaran^1*, Carolina Berger^3*, Boris Fehse, PhD^3* and Nicolaus Kroeger, MD²

¹University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
²Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
³Department of Stem Cell Transplantation, Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Mengmeng Dong^1*, Jinna Zhang^1*, Qingxiao Chen^1*, Honghua He^1*, Haimeng Yan^1*, Gaofeng Zheng, MD^1*, Xiaoyan Han^1*, He Huang^1,2, Jingsong He, PhD^1* and Zhen Cai, PhD, MD^3*

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
²Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou 311121, China, Hangzhou, China
³Institute of Hematology, Zhejiang University, Hangzhou, China

Jeries Kort, MD^1,2, Leland Metheny, MD³, Pingfu Fu, PhD^4*, Shufen Cao^4*, James J. Driscoll, MD, PhD⁵ and Ehsan Malek, MD³

¹Department of Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH
²Case Western University, Cleveland, OH
³Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
⁴Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH
⁵Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH

Malin Hultcrantz, MD, PhD¹, Andriy Derkach, PhD^2*, Hani Hassoun, MD¹, Neha Korde, MD³, Kylee H Maclachlan, MBBCh, PhD¹, Sham Mailankody, MBBS ⁴, Dhwani Patel, MD^1*, Urvi A Shah, MD¹, Carlyn Tan, MD⁵, Theresia Akhlaghi, MD^1*, Issam S. Hamadeh, PharmD¹, David J. Chung, MD, PhD⁶, Oscar B Lahoud, MD⁶, Heather Landau, MD⁶, Michael Scordo, MD⁷, Gunjan L. Shah, MD^8*, Sergio A. Giralt, MD, FACP, FASTCT^9*, Alexander M Lesokhin, MD¹ and Saad Usmani, MD¹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY
⁴Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, New York, NY
⁵Memorial Sloan Kettering Cancer Center, NY, NY
⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
⁸Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

Qingqing Wang, MD^1*, Li Yao, MD, PhD^2*, Mingqing Zhu^3*, Lingzhi Yan, MD, PhD^4*, Song Jin, MD, PhD^1*, Jingjing Shang, MD, PhD^1*, Xiaolan Shi, MD, PhD^1*, Yingying Zhai, MD^1*, Shuang Yan, MD^1*, Weiqin Yao, MD^1*, You Hongying, MD^5*, Depei Wu¹ and Chengcheng Fu, MD, PhD^6*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China
³National Clinical Research Center For Hematologic Diseases, Jiangsu Institute of, Suzhou, CHN
⁴Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
⁵The First Affiliated Hospital of Soochow University, Suzhou, 215000, Jiangsu Province, China, suzhou, China
⁶The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

Michael Sheu, MD^1*, Sofia Molina Garcia, MD^1*, Meera Patel, MD^1*, Lauren M Granat, DO, MS^1*, Puneet Dhillon, DO^1*, Hussein Awada^2*, Faiz Anwer, MD³, Jack Khouri, MD⁴, Louis S. Williams, MD⁴, Joslyn Rudoni, PharmD^5* and Aneela Majeed, MD^6*

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
³Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
⁴Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁵Department of Pharmacy, Cleveland Clinic, Cleveland, OH
⁶Department of Infectious Disease, Cleveland Clinic, Cleveland, OH

Marie-Emilie Willemin^1*, Shun Xin Wang Lin^2*, Loeckie De Zwart^1*, Liviawati S. Wu^3*, Xin Miao^2*, Raluca Verona^2*, Arnob Banerjee^2*, Baolian Liu^4*, Rachel Kobos⁴, Ming Qi⁴, Daniele Ouellet^2*, Jenna D. Goldberg^4* and Suzette Girgis²

¹Janssen Research & Development, Beerse, Belgium
²Janssen Research & Development, Spring House, PA
³Janssen Research & Development, South San Francisco, CA
⁴Janssen Research & Development, Raritan, NJ

Wenqiang Yan^1,2*, Lingna Li^1*, Huishou Fan^1*, Jingyu Xu^3*, Shuhui Deng, MD^4*, Weiwei Sui^4*, Yan Xu^4*, Dehui Zou^4*, Lugui Qiu⁵ and Gang An, MD^5*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
²State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, TianJin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Alicia Bao, BS¹, Ruchi Kudalkar^2*, Jose Rodriguez^3*, Qiuhong Zhao, MS^4*, Nidhi Sharma, PhD^2*, Naresh Bumma, MD⁵, Srinivas Devarakonda, MD⁶, Abdullah Khan, MBBS, MSc⁷, Ashley E. Rosko, MD⁴, Elvira Umyarova, MD⁸, Don M. Benson Jr., MD⁹ and Francesca Cottini, MD¹⁰

¹College of Medicine, The Ohio State University College of Medicine, Dublin, OH
²The Ohio State University, Columbus, OH
³Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁴Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁵Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁶The Ohio State University Wexner Medical Center, Columbus, OH
⁷Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁸Division of Hematology, The Ohio State University, Columbus, OH
⁹Riney Family Myeloma Center for Research Excellence, The Ohio State University Medical Center, Columbus, OH
¹⁰Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH

Moshe Mittelman, MD^1,2, Howard S. Oster, MD PhD^3,4, Yatir Ben Shlomo, PhD^5*, Ariel Israel, MD PhD^6*, Osnat Jarchowcky Dolberg, MD^7*, Samah Hayek, PhD^5*, Michael Leshchinsky, BSc^5*, Eldad Kepten, BSc^5*, Ran Balicer, MD, PhD^5* and Galit Shaham, PhD^5*

¹Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
²Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
⁴Department of Internal Medicine A, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, Israel
⁵Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel
⁶Leumit Health Services, Tel Aviv, Israel
⁷Hematology Department, Meir Medical Center, Kfar Saba, Israel